Leucadia National - TARSUS PHARMACEUTICALS INC ownership

TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 75 filers reported holding TARSUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 4.80 and the average weighting 0.2%.

Quarter-by-quarter ownership
Leucadia National ownership history of TARSUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,877,570
-8.6%
330,758
-7.0%
0.05%
-8.6%
Q2 2023$6,428,547
+14.7%
355,758
-20.2%
0.06%
+28.9%
Q1 2023$5,603,178
-14.3%
445,7580.0%0.04%0.0%
Q4 2022$6,534,812445,7580.04%
Other shareholders
TARSUS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Vivo Capital, LLC 2,987,331$67,215,0004.05%
FRAZIER MANAGEMENT LLC 1,417,157$31,886,0002.46%
Cormorant Asset Management, LP 1,403,331$31,575,0001.88%
Ghost Tree Capital, LLC 170,000$3,825,0001.37%
COWEN AND COMPANY, LLC 514,289$11,572,0001.05%
Sands Capital Ventures, LLC 260,000$5,850,0000.87%
RTW INVESTMENTS, LP 2,013,601$45,306,0000.66%
Perceptive Advisors 2,592,832$58,338,0000.45%
TimesSquare Capital Management, LLC 660,800$14,868,0000.13%
Jefferies Group LLC 422,993$9,517,3430.06%
View complete list of TARSUS PHARMACEUTICALS INC shareholders